The Hidden Cost of Translation Rework in LATAM Clinical Trials

Ask any sponsor what their biggest cost overrun was on a LATAM clinical trial, and they will mention site delays, enrollment timelines, or regulatory review cycles. Almost none of them will mention translation rework.

But when you trace the actual spend, translation rework is frequently the single largest unbudgeted line item in a multi-country LATAM submission. Not because translation is expensive. Because doing it twice, three times, or four times while the regulatory clock resets each time is extraordinarily expensive.

A typical multi-country submission involves 15 to 40 documents per country, depending on whether it is a device registration, a clinical trial application, or both. Across five countries, that is 75 to 200 documents.

Each document is translated once by the vendor. The vendor delivers. The sponsor files. The regulator reviews.

Then the RFIs come back.

A single RFI on a translation issue requires: identifying the specific error, correcting the translation, re-certifying or re-swearing the corrected document, resubmitting to the regulator, and waiting for the review clock to restart. That cycle takes 30 to 60 days minimum per RFI, per country.

If the same translation error appears in three countries (because the same vendor made the same mistake in a document filed in all three), the sponsor now has three parallel rework cycles running simultaneously. Three sets of corrected translations, three resubmissions, three restarted review clocks.

Consider a real scenario. A sponsor files a device registration in Brazil, Mexico, Colombia, Argentina, and Peru. The translation vendor delivers all documents on time and on budget. The initial translation cost is approximately $35,000 across all five countries.

ANVISA flags a sworn translation issue on the technical summary. COFEPRIS issues a prevención because the device description does not match their preferred terminology. INVIMA flags an inconsistency between the IFU and the registration application.

Each RFI triggers:

Direct translation cost: $2,000 to $5,000 per corrected document set, per country. For three countries, that is $6,000 to $15,000 in translation rework alone.

Regulatory consulting cost: The sponsor's regulatory affairs team or external RA consultant spends 15 to 30 hours per RFI response, across internal review, regulator communication, and resubmission. At $200 to $400 per hour, that is $3,000 to $12,000 per RFI.

Timeline cost: Each RFI adds 60 to 120 days to the country-specific timeline. For a medical device with $50,000 to $200,000 in monthly revenue potential per country, a 90-day delay in three countries represents $450,000 to $1,800,000 in deferred revenue.

Total rework cost from three translation-triggered RFIs: $459,000 to $1,827,000 in combined direct costs and deferred revenue. Against an original translation budget of $35,000.

The translation was the cheapest line item in the submission budget. The rework was the most expensive.

Translation rework in LATAM submissions is not caused by bad translators. It is caused by a structural mismatch between how translation vendors work and how LATAM regulators review.

Translation vendors optimize for linguistic accuracy: correct terminology, consistent grammar, faithful rendering of the source text. These are the right metrics for general medical translation.

LATAM regulators evaluate submissions on regulatory compliance: does the document use the terminology we expect, in the format we require, with the translation type we specified, and is it consistent with every other document in the dossier? These are regulatory metrics, not linguistic ones.

A translation can score perfectly on every linguistic metric and still fail every regulatory metric. That gap is where rework lives.

The only way to eliminate translation rework is to build the regulatory requirements into the translation process from the beginning, not as a quality check at the end.

This means:

Pre-submission regulatory mapping. Before translating a single document, map every country's requirements: which documents need sworn versus certified translations, which terminology conventions each regulator uses, which document-type formatting each authority expects.

Cross-document consistency validation. Before delivery, validate that every instance of the device name, intended use description, and key specifications is identical across every document in the dossier. One inconsistency across 40 documents is enough to trigger an RFI.

Physician-led clinical review. For clinical documents (protocols, ICFs, clinical study reports), linguistic QC is not enough. A physician reviewer who understands both the science and the local regulatory context needs to validate that the translation preserves the clinical meaning, not just the words.

Regulator-specific terminology libraries. Maintained glossaries per regulator, updated with every submission cycle, so the translator uses the exact terms each authority expects.

At Amavita Sciences™, we built our Six-Gate QC process specifically to eliminate translation rework. Every project goes through regulatory routing, terminology mapping, translation, medical review, cross-document validation, and final regulatory compliance check before delivery.

We guarantee First-Pass Acceptance. If a regulator issues an RFI on a translation we delivered, we correct it at no additional cost. We can make that guarantee because our process catches the issues that generic vendors miss, before the submission is filed.

The cost of our service is higher than a generic translation vendor. The total cost of submission, including rework, delays, and deferred revenue, is dramatically lower.

When evaluating translation vendors for a LATAM submission, the question is not "what is the cost per word?" The question is "what is the total cost of submission, including rework?"

If the vendor cannot tell you their RFI rate on previous LATAM submissions, they do not track it. If they do not track it, they are not optimizing for it. And if they are not optimizing for it, you will pay for rework.

The cheapest translation is the one that does not come back.